AAPP Scientific Poster Session Abstracts

Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.

Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024

Currently Viewing Abstracts from 2006

Title
A 12-WEEK OPEN LABEL STUDY OF HIGH DOSE QUETIAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF OLANZAPINE IN ADOLESCENTS WITH SCHIZOPHRENIA
A FIXED DOSE STUDY OF THE EFFICACY AND SAFETY OF DULOXETINE FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER
A proton magnetic resonance spectroscopy study of the effects of lithium on myo-inositol in bipolar depressed adolescents
A Retrospective Chart Review of Topiramate-Induced Weight Loss in Patients with Psychotropic-Induced Weight Gain
A RETROSPECTIVE EVALUATION OF THE EFFECT OF RECENTLY-DIAGNOSED DEPRESSION ON GLYCEMIC CONTROL IN DIABETIC VA PATIENTS
Acetylcholinesterase Inhibitor-Induced Dystonia
Actos Induced Aggression: A Case Report
Adherence to Metabolic Monitoring and Assessment of Risk Factors for Diabetes Mellitus in Patients on Atypical Antipsychotics
ADVERSE OUTCOMES ASSOCIATED WITH THE USE OF ATYPICAL ANTIPSYCHOTICS FOR THE MANAGEMENT OF BEHAVIORAL AND PSYCHOLOGICAL SIGNS AND SYMPTOMS OF DEMENTIA
An Evaluation of Lamotrigine on Mood in Older Adults with Epilepsy and Comorbid Depressive Symptoms
ANALYSIS OF VENLAFAXINE XR TREATMENT IN PREVENTING RECURRENCE IN PATIENTS WITH RECURRENT UNIPOLAR MAJOR DEPRESSION: A PLACEBO-CONTOLLED TRIAL
Analysis to Correlate Serum Concentrations of Quetiapine and Risperidone with Efficacy, Side Effects and Tolerability
ANTIPSYCHOTIC ADHERENCE: AN ASSESSMENT OF PATIENT SELF-REPORT, ATTITUDES, INSIGHT AND ABILITY
Aripiprazole vs Olanzapine in Schizophrenia: A 52-Week, Open-Label Study
ASSESSING RESILIENCE AS A PREDICTOR OF REMISSION IN PTSD: AN ANALYSIS OF PATIENTS TREATED WITH VENLAFAXINE XR OR PLACEBO
Assessment of Infection Risk during Clozapine Treatment in an Iowa Medicaid Population
Assessment of Pharmacists' Perceptions of Psychiatric Medications and Illnesses
ASSESSMENT OF VITAL SIGNS IN CHILDREN AND ADOLESCENTS TREATED WITH ADHD MEDICATIONS
ASSOCIATION BETWEEN MEDICATION CHANGES AND FALLS IN GERIATRIC PSYCHIATRY PATIENTS
ATOMOXETINE IN ADOLESCENTS WITH ADHD AND COMORBID DEPRESSION
ATOMOXETINE TREATMENT FOR PEDIATRIC PATIENTS WITH ADHD AND COMORBID ANXIETY
Bipolar Disorder: Relationship Between Body Mass Index and Quality of Life
Comparison of Olanzapine, Quetiapine, and Risperidone in First-Episode Psychosis: A Randomized, 52-Week Trial
Depression as a risk factor for worsening platelet aggregation in stage five chronic kidney disease (CKD) patients receiving hemodialysis
Determining the mechanism of a drug-drug interaction: Venlafaxine and P-glycoprotein
DEVELOPMENT OF AN INTERDICISPLINARY TREATMENT REFRACTORY DEPRESSION CLINIC
Donepezil to galantamine conversion: rapid titration tolerability.
DOSING AND SWITCHING PATTERNS OF MIGRAINE PREVENTION THERAPY IN THE MANAGED CARE SETTING
DULOXETINE AS AN EFFECTIVE TREATMENT FOR IMPROVING PAINFUL PHYSICAL SYMPTOMS AND FUNCTIONING ASSOCIATED WITH GENERALIZED ANXIETY DISORDER
DULOXETINE IN THE MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN: RESPONSE PROFILE
DULOXETINE: META-ANALYSES OF SUICIDAL BEHAVIORS AND THOUGHTS IN CLINICAL TRIALS FOR MAJOR DEPRESSIVE DISORDER
Effect of Bupropion on Physiological Measures of Stress in Smokers During Nicotine Withdrawal
Efficacy of Quetiapine Monotherapy in Bipolar Depression: A Confirmatory Double-Blind, Placebo-Controlled Study (The BOLDER II Study)
Estimating Risk Factors for Diabetes Among Schizophrenics with Exposure to Atypical Antipsychotics.
EVALUATING PREDICTORS BASED ON A POOLED ANALYSIS OF VENLAFAXINE XR IN THE SHORT-TERM TREATMENT OF PANIC DISORDER
EVALUATION OF DIVALPROEX SODIUM DELAYED-RELEASE DOSING IN ADULT, CHILD, AND ADOLESCENT INPATIENTS ADMITTED TO A PSYCHIATRIC UNIT AT A UNIVERSITY MEDICAL CENTER
Evaluation of Long-Acting Injectable Risperidone for Older Adult Inpatients with Psychosis
EVALUATION OF PATIENT RISKS ASSOCIATED WITH CONCURRENT USE OF LINEZOLID WITH SEROTONIN REUPTAKE INHIBITORS
EVALUATION OF THE TIMELINE TO MAINTENANCE ANTIPSYCHOTIC THERAPY IN AN INPATIENT PSYCHIATRIC HOSPITAL
EVALUATION OF THE USE OF LOW DOSE ANTIPSYCHOTICS IN THE TREATMENT OF NONPSYCHOTIC POSTTRAUMATIC STRESS DISORDER
EVALUATION OF UTILIZATION AND DOCUMENTATION OF PRO RE NATA (PRN) PSYCHOTROPIC MEDICATIONS
Evaluation of Weight Gain and Extrapyramidal Symptoms in Forensic, Chronically Ill Psychiatric Patients
High Risk - High Alert Medication Management in a State Psychiatric Facility
Hyperlipidemia following Treatment with Second-Generation Antipsychotic Medications
Impact of Community Pharmacist-Provided Medication Therapy Management on Outcomes in Opiate Dependence
Improvement in the Quality of Life in People with Epilepsy and Comorbid Depressive Symptoms after Lamotrigine Adjunctive Therapy
INFLUENCE OF MAJOR DEPRESSIVE DISORDER ON THE PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF METHADONE
Intramuscular Aripiprazole in Acute Schizophrenia: A Pivotal Phase 3 Study
Intramuscular Aripiprazole vs. Placebo for Agitation in Acute Mania
Intraparenchymal hemorrhage associated with sildenafil
Jimson weed induced acute psychosis in a 14-year-old patient
LOW INCIDENCE OF COGNITIVE AND BEHAVIORAL ADVERSE EVENTS IN RASAGILINE-TREATED PATIENTS WITH EARLY TO ADVANCED PARKINSON’S DISEASE (PD)
Maintenance of Response to Memantine Treatment in Moderate to Severe Alzheimer’s Disease Patients Receiving Stable Donepezil Treatment
Medication reconciliation and discharge clinic on an inpatient psychiatric unit: A pilot study
Medication Reconciliation Model in an Acute Care Psychiatric Facility
Medication Utilization Patterns and Methods of Suicidality in Borderline Personality Disorder
Metabolic Effects Associated with Atypical Antipsychotic Treatment in the Developmentally Disabled
METABOLIC MONITORING INITIATIVE IN AN ACUTE CARE PSYCHIATRIC HOSPITAL SETTING
Naltrexone's Effect on Weight Gain in Adolescent Patients Receiving Second Generation Antipsychotics
Neuroleptic Malignant Syndrome due to Long Acting Intramuscular Risperidone and Successful Rechallenge With an Extended Interval Dosing Regimen
OFF-LABEL USE OF ATYPICAL ANTIPSYCHOTICS
OLANZAPINE IN THE TREATMENT OF ACUTE MANIC OR MIXED EPISODES IN ADOLESCENTS; A 3-WEEK RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
OLANZAPINE/FLUOXETINE COMBINATION VERSUS LAMOTRIGINE IN THE LONG-TERM TREATMENT OF BIPOLAR I DEPRESSION
ONSET OF ANTIDEPRESSANT ACTION AND ACUTE EFFICACY AND SAFETY OF DULOXETINE VERSUS ESCITALOPRAM AND PLACEBO IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
PATTERNS OF TOPIRAMATE UTILIZATION AMONG COMMERCIALLY INSURED PATIENTS: DIAGNOSIS, COMORBIDITIES, AND REAL-WORLD DOSING
Patterns of topiramate utilization among Medicaid patients: diagnosis, comorbidities and real-world dosing
Pica Episodes Following Initiation of Bupropion in an Institutionalized Developmentally Disabled Adult
Possible Intranasal Quetiapine Misuse: A Case Report
Pre-screening of Metabolic Abnormalities among Patients with Serious Mental Illness and Concurrent Antipsychotic Therapy
PREDICTING REMISSION IN DEPRESSED OUTPATIENTS TREATED WITH VENLAFAXINE EXTENDED RELEASE (XR) OR SELECTIVE SEROTONIN REUPTAKE INHIBITORS BASED ON SYMPTOM IMPROVEMENT PATTERNS
Prevalence and Use of Second Generation Antipsychotics in Children Age 0-11 Enrolled in a Medicaid Behavioral Health Managed Care Plan
Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationships with the age of initiation of prescribed stimulants.
Psychiatric Comorbidity Does Not Predict Interferon Treatment
PSYCHIATRIC PHARMACIST INTERVENTION AND CONSULTATION IN A LIVER CLINIC
RASAGILINE IS EFFECTIVE AS MONOTHERAPY IN PATIENTS WITH EARLY PARKINSON’S DISEASE (PD) AND AS ADJUNCTIVE THERAPY IN MODERATE TO ADVANCED PD.
Real World Usage of Weight Gain Drugs in Patients on Second-Generation Antipsychotics
Real World Usage of Weight Gain Drugs in Patients on Second-Generation Antipsychotics
Relapse rates in Schizophrenic Patients Receiving Aripiprazole in Comparison to Other Atypical Antipsychotics
Remission in Schizophrenia: The Relationship to Baseline Symptoms and Changes in Symptom Domains During a One-Year Study.
Risks for CHD (Coronary Heart Disease) in Newly Admitted Adult Psychiatry Inpatients
Risperidone monotherapy versus risperidone or haloperidol plus sertraline for major depression with psychosis: results of a pilot, double-blind, placebo-controlled trial
Safety and Tolerability of the Selegiline Transdermal System 20 mg for Treatment of Major Depression
Safety Profile associated with the concomitant use of lorazepam injection with olanzapine, ziprasidone or haloperidol injection.
Selective Serotonin Reuptake Inhibitors and Risk of Gastrointestinal Bleeding
SEROTONIN TRANSPORTER GENE POYMORPHISM IN HCV PATIENTS: PRELIMINARY FINDINGS
SSRI-Induced Ecchymosis
The Association of Selective Serotonin Reuptake Inhibitors (SSRIs) and Hospitalization Rates in Patients with Alcohol Abuse and Alcohol Dependence
THE DOPAMINE-2 RECEPTOR TAQAI POLYMORPHISM, PROLACTIN ELEVATION, AND BONE MINERAL DENSITY IN PERSONS WITH SCHIZOPHRENIA
THE EFFECT OF OLANZAPINE AND RISPERIDONE ON TRIGLYCERIDES AND CHOLESTEROL IN CHILDREN AND ADOLESCENTS
The Effects of Haloperidol on Triglyceride Levels in Men and Women
THE FIRST 21-MONTHS OF SAFETY EXPERIENCE WITH POST-MARKETING USE OF OLANZAPINE’S INTRAMUSCULAR FORMULATION
The Prevalence of Thyroid Dysfunction in the Severe and Persistently Mentally ill
TOPIRAMATE FOR MIGRAINE PREVENTION IN THE MANAGED CARE SETTING
TREATMENT DISCONTINUATION IN ANTIPSYCHOTIC TRIALS AND CHANGE IN SCHIZOPHRENIA SYMPTOMS
Urine drug screen false positive for phencyclidine from use of diazepam and/or promethazine
USE OF A BIOMARKER OF NOREPINEPHRINE TRANSPORTER (NET) INHIBITION TO ASSESS ATOMOXETINE EFFECTS DURING CLINICALLY RECOMMENDED DOSING
Utilizing Pharmacy Student Conducted Telephone Follow-Up to Assess Medication Adherence in Discharged Psychiatric Patients
Value of the Pharmacist Obtained Medication History on a Behavioral Health Unit
Weight Changes Following Switch From Oral Antipsychotics to Risperidone Long Acting Injection: A Retrospective Chart Review
YMRS Line Analysis of Aripiprazole in Acute Mania: Pooled Data